Biodesign Institute's DNA Synbodies Could Be Cheaper, Easier Antibody Alternative | GenomeWeb

By Adam Bonislawski

Scientists at Arizona State University's Biodesign Institute have developed a new form of affinity reagent that could offer an easy-to-produce alternative to traditional antibodies.

Dubbed DNA synbodies, the agents consist of pairs of peptides linked by a DNA backbone. In an early study they showed equivalent or better sensitivity and specificity compared to commercial antibodies, said John Chaput, an associate professor at ASU and one of the inventors of the technology.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PLOS this week: researchers explore the transfer of host genetic material into viruses, and more.

It's too difficult to correct or retract a flawed scientific paper, researchers write in Nature.

A proposed bill would require NSF to only fund research that's in "the national interest."

Australia's Commonwealth Scientific and Industrial Research Organisation plans to eliminate up to 350 jobs.